Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Clinical value of dark-blood late gadolinium enhancement cardiovascular magnetic resonance without additional magnetization preparation
Indexado
WoS WOS:000477713400001
Scopus SCOPUS_ID:85069841464
DOI 10.1186/S12968-019-0556-1
Año 2019
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



BackgroundFor two decades, bright-blood late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) has been considered the reference standard for the non-invasive assessment of myocardial viability. While bright-blood LGE can clearly distinguish areas of myocardial infarction from viable myocardium, it often suffers from poor scar-to-blood contrast, making subendocardial scar difficult to detect. Recently, we proposed a novel dark-blood LGE approach that increases scar-to-blood contrast and thereby improves subendocardial scar conspicuity. In the present study we sought to assess the clinical value of this novel approach in a large patient cohort with various non-congenital ischemic and non-ischemic cardiomyopathies on both 1.5T and 3T CMR scanners of different vendors.MethodsThree hundred consecutive patients referred for clinical CMR were randomly assigned to a 1.5T or 3T scanner. An entire short-axis stack and multiple long-axis views were acquired using conventional phase sensitive inversion recovery (PSIR) LGE with TI set to null myocardium (bright-blood) and proposed PSIR LGE with TI set to null blood (dark-blood), in a randomized order. The bright-blood LGE and dark-blood LGE images were separated, anonymized, and interpreted in a random order at different time points by one of five independent observers. Each case was analyzed for the type of scar, per-segment transmurality, papillary muscle enhancement, overall image quality, observer confidence, and presence of right ventricular scar and intraventricular thrombus.ResultsDark-blood LGE detected significantly more cases with ischemic scar compared to conventional bright-blood LGE (97 vs 89, p=0.008), on both 1.5T and 3T, and led to a significantly increased total scar burden (3.32.4 vs 3.0 +/- 2.3 standard AHA segments, p=0.015). Overall image quality significantly improved using dark-blood LGE compared to bright-blood LGE (81.3% vs 74.0% of all segments were of highest diagnostic quality, p=0.006). Furthermore, dark-blood LGE led to significantly higher observer confidence (confident in 84.2% vs 78.4%, p=0.033).Conclusions The improved detection of ischemic scar makes the proposed dark-blood LGE method a valuable diagnostic tool in the non-invasive assessment of myocardial scar. The applicability in routine clinical practice is further strengthened, as the present approach, in contrast to other recently proposed dark- and black-blood LGE techniques, is readily available without the need for scanner adjustments, extensive optimizations, or additional training.

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Cardiac & Cardiovascular Systems
Radiology, Nuclear Medicine & Medical Imaging
Cardiac & Cardiovascular System
Scopus
Radiology, Nuclear Medicine And Imaging
Radiological And Ultrasound Technology
Cardiology And Cardiovascular Medicine
Family Practice
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Holtackers, Robert J. Hombre Maastricht Univ - Países Bajos
Kings Coll London - Reino Unido
Maastricht University - Países Bajos
King's College London - Reino Unido
Cardiovascular Research Institute Maastricht - Países Bajos
St Thomas' Hospital - Reino Unido
Universiteit Maastricht - Países Bajos
CARIM School for Cardiovascular Disease - Países Bajos
Maastricht Universitair Medisch Centrum+ - Países Bajos
2 Van De Heyning, Caroline M. Mujer Kings Coll London - Reino Unido
St Thomas Hosp - Reino Unido
Antwerp Univ Hosp - Bélgica
Univ Antwerp - Bélgica
King's College London - Reino Unido
Guy's and St Thomas' NHS Foundation Trust - Reino Unido
Universitair Ziekenhuis Antwerpen - Bélgica
Universiteit Antwerpen - Bélgica
St Thomas' Hospital - Reino Unido
3 Nazir, Muhummad Sohaib - Kings Coll London - Reino Unido
St Thomas Hosp - Reino Unido
King's College London - Reino Unido
Guy's and St Thomas' NHS Foundation Trust - Reino Unido
St Thomas' Hospital - Reino Unido
4 Rashid, Imran Hombre Kings Coll London - Reino Unido
St Thomas Hosp - Reino Unido
King's College London - Reino Unido
Guy's and St Thomas' NHS Foundation Trust - Reino Unido
St Thomas' Hospital - Reino Unido
5 Ntalas, Ioannis Hombre Kings Coll London - Reino Unido
St Thomas Hosp - Reino Unido
King's College London - Reino Unido
Guy's and St Thomas' NHS Foundation Trust - Reino Unido
St Thomas' Hospital - Reino Unido
6 Rahman, Haseeb Hombre Kings Coll London - Reino Unido
St Thomas Hosp - Reino Unido
King's College London - Reino Unido
Guy's and St Thomas' NHS Foundation Trust - Reino Unido
St Thomas' Hospital - Reino Unido
7 Botnar, Reneprime M. Hombre Kings Coll London - Reino Unido
Pontificia Universidad Católica de Chile - Chile
King's College London - Reino Unido
St Thomas' Hospital - Reino Unido
8 Chiribiri, Amedeo Hombre Kings Coll London - Reino Unido
King's College London - Reino Unido
St Thomas' Hospital - Reino Unido

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Origen de Citas Identificadas



Muestra la distribución de países cuyos autores citan a la publicación consultada.

Citas identificadas: Las citas provienen de documentos incluidos en la base de datos de DATACIENCIA

Citas Identificadas: 2.44 %
Citas No-identificadas: 97.56 %

Muestra la distribución de instituciones nacionales o extranjeras cuyos autores citan a la publicación consultada.

Citas identificadas: Las citas provienen de documentos incluidos en la base de datos de DATACIENCIA

Citas Identificadas: 2.44 %
Citas No-identificadas: 97.56 %

Financiamiento



Fuente
FONDECYT
Fondo Nacional de Desarrollo Científico y Tecnológico
Medical Research Council
EPSRC
UK Medical Research Council
British Heart Foundation
Engineering and Physical Sciences Research Council
Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica
Research Councils UK
King's College London
FONDECYT N
Welcome EPSRC Centre for Medical Engineering
Stichting de Weijerhorst
NIHR Biomedical Research Centre (BRC)
Department of Health through the National Institute for Health Research (NIHR) Healthcare Technology Cooperative for Cardiovascular Diseases at Guy's and St Thomas' NHS Foundation Trust
National Institute for Health Research
NIHR Imperial Biomedical Research Centre
Heart of England NHS Foundation Trust
King’s College London
Department of Health, Australian Government
Guy’s and St Thomas’ NHS Foundation Trust
Guy's and St Thomas' NHS Foundation Trust
NIHR Bristol Biomedical Research Centre
Manchester Biomedical Research Centre
EPSRC Centre for Medical Engineering
Healthcare Technology Co-operative for Cardiovascular Diseases
Department of Health and Social Care

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
The authors acknowledge financial support from Stichting de Weijerhorst, the British Heart Foundation (RG/12/1/29262), the EPSRC (EP/P001009/1 and EP/P007619/1), the Welcome EPSRC Centre for Medical Engineering (NS/A000049/1 and WT/203148/Z/16/Z), the UK Medical Research Council (MR/P01979X/1), the FONDECYT No 1161051, the Department of Health through the National Institute for Health Research (NIHR) Healthcare Technology Cooperative for Cardiovascular Diseases at Guy's and St Thomas' NHS Foundation Trust, and the NIHR Biomedical Research Centre (BRC) awarded to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, and/or the Department of Health.
The authors acknowledge financial support from Stichting de Weijerhorst, the British Heart Foundation (RG/12/1/29262), the EPSRC (EP/P001009/1 and EP/P007619/1), the Welcome EPSRC Centre for Medical Engineering (NS/ A000049/1 and WT/203148/Z/16/Z), the UK Medical Research Council (MR/ P01979X/1), the FONDECYT N° 1161051, the Department of Health through the National Institute for Health Research (NIHR) Healthcare Technology Co-operative for Cardiovascular Diseases at Guy’s and St Thomas’ NHS Foundation Trust, and the NIHR Biomedical Research Centre (BRC) awarded to Guy’s & St Thomas’ NHS Foundation Trust in partnership with King’s College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, and/or the Department of Health.

Muestra la fuente de financiamiento declarada en la publicación.